CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma

NCT04812691 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL: JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)

Sponsor

Shanghai Ming Ju Biotechnology Co., Ltd.